Cargando…

Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity

Detalles Bibliográficos
Autores principales: Batista, Marta Vaz, Perez-Garcia, José, Eiriz, Inês, Gion, Maria, Llombart, Antonio, Braga, Sofia, Cortés, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632579/
https://www.ncbi.nlm.nih.gov/pubmed/37970592
http://dx.doi.org/10.21037/atm-23-1603
_version_ 1785146142988697600
author Batista, Marta Vaz
Perez-Garcia, José
Eiriz, Inês
Gion, Maria
Llombart, Antonio
Braga, Sofia
Cortés, Javier
author_facet Batista, Marta Vaz
Perez-Garcia, José
Eiriz, Inês
Gion, Maria
Llombart, Antonio
Braga, Sofia
Cortés, Javier
author_sort Batista, Marta Vaz
collection PubMed
description
format Online
Article
Text
id pubmed-10632579
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-106325792023-11-15 Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity Batista, Marta Vaz Perez-Garcia, José Eiriz, Inês Gion, Maria Llombart, Antonio Braga, Sofia Cortés, Javier Ann Transl Med Editorial Commentary | Emerging Therapeutics AME Publishing Company 2023-10-17 2023-10-25 /pmc/articles/PMC10632579/ /pubmed/37970592 http://dx.doi.org/10.21037/atm-23-1603 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary | Emerging Therapeutics
Batista, Marta Vaz
Perez-Garcia, José
Eiriz, Inês
Gion, Maria
Llombart, Antonio
Braga, Sofia
Cortés, Javier
Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
title Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
title_full Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
title_fullStr Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
title_full_unstemmed Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
title_short Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
title_sort preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
topic Editorial Commentary | Emerging Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632579/
https://www.ncbi.nlm.nih.gov/pubmed/37970592
http://dx.doi.org/10.21037/atm-23-1603
work_keys_str_mv AT batistamartavaz preclinicalandclinicalefficacyoftrastuzumabderuxtecaninbreastcancerbrainmetastasesanewinsightoncentralnervoussystemactivity
AT perezgarciajose preclinicalandclinicalefficacyoftrastuzumabderuxtecaninbreastcancerbrainmetastasesanewinsightoncentralnervoussystemactivity
AT eirizines preclinicalandclinicalefficacyoftrastuzumabderuxtecaninbreastcancerbrainmetastasesanewinsightoncentralnervoussystemactivity
AT gionmaria preclinicalandclinicalefficacyoftrastuzumabderuxtecaninbreastcancerbrainmetastasesanewinsightoncentralnervoussystemactivity
AT llombartantonio preclinicalandclinicalefficacyoftrastuzumabderuxtecaninbreastcancerbrainmetastasesanewinsightoncentralnervoussystemactivity
AT bragasofia preclinicalandclinicalefficacyoftrastuzumabderuxtecaninbreastcancerbrainmetastasesanewinsightoncentralnervoussystemactivity
AT cortesjavier preclinicalandclinicalefficacyoftrastuzumabderuxtecaninbreastcancerbrainmetastasesanewinsightoncentralnervoussystemactivity